Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase II trial for Epidermolysis bullosa (PO) in USA and Europe

Trial Profile

Phase II trial for Epidermolysis bullosa (PO) in USA and Europe

Planning
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 09 Dec 2018

At a glance

  • Drugs Angiotensin-1-7 (Primary)
  • Indications Epidermolysis bullosa
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Dec 2018 New trial record
    • 27 Nov 2018 According to Constant Pharmaceuticals media release, study is expected to start in 2019
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top